According to our (Global Info Research) latest study, the global Safety IV Catheter market size was valued at US$ 2601 million in 2025 and is forecast to a readjusted size of US$ 3777 million by 2032 with a CAGR of 5.1% during review period.
Safety IV catheters are sterile, single-use intravascular catheter products designed for short-term peripheral vascular access. Their core function is to establish stable vascular access for patients during infusion, drug administration, blood sampling, blood pressure monitoring, and selected power-injection contrast imaging procedures, while reducing nursing risks such as needlestick injuries, exposure to bloodborne pathogens, blood leakage contamination, and repeated punctures through structures including needle-tip shielding, inner-needle retraction, metallic clip protection, full-encapsulation sleeves, hemostatic valves, blood-control valves, and closed connection systems. These products typically consist of a metal introducer needle, peripheral catheter, catheter hub, flashback chamber, protective housing, needle-tip protection mechanism, injection port, extension tube, valve components, and sterile packaging. Catheter materials include polyurethane, polytetrafluoroethylene, fluorinated ethylene propylene, and thermosensitive polyurethane. Common sizes generally range from 14G to 26G, with different models developed for adult, pediatric, neonatal, routine infusion, blood-control, and power-injectable use scenarios. Typical customers include general hospitals, emergency centers, operating rooms, ICUs, pediatric departments, imaging departments, outpatient infusion centers, distributors, and OEM medical consumable brands.
The industrial value of safety IV catheters is shifting from a single venipuncture consumable to a standardized medical device that combines vascular access, safety protection, and nursing workflow management. Peripheral venous access is one of the most common basic procedures in clinical care. Conventional IV catheters mainly address continuous infusion and reduce repeated punctures, but occupational exposure risks remain during needle withdrawal, catheter connection, blood leakage, and sharps disposal. As hospitals place greater emphasis on infection control, occupational protection, and nursing quality, safety-engineered products are becoming an increasingly important procurement direction. The essence of product upgrading is not simply adding a protective shell, but building a complete risk-control system around the cannulation process, including flashback visualization, automated needle-tip protection, blood-control valves, closed connections, catheter flexibility, radiopacity, and size selection. For hospitals, these products can reduce needlestick injuries, limit blood contamination, improve procedural consistency, and enhance safety in high-frequency settings such as emergency departments, ICUs, operating rooms, pediatric units, and imaging departments. Therefore, market growth is driven more by clinical standard upgrades and replacement within hospital consumable portfolios than by patient volume alone.
The competitive landscape is characterized by the coexistence of technology-driven product portfolios from international leaders and cost-efficient manufacturing from regional suppliers. Companies in Europe, the United States, and Japan generally build barriers around safety mechanisms, material systems, clinical training, and regulatory certification, with portfolios covering active retraction, passive protection, blood control, closed systems, power-injectable models, and pediatric or neonatal sizes. Manufacturers in India, China, South Korea, and Vietnam are competitive in production cost, size coverage, OEM supply, and regional channels, and some have launched products with blood control, power-injection capability, needlestick protection, and closed-system structures. Safety mechanism is the key factor in competitive segmentation. Passive clips and full-encapsulation sleeves emphasize automation and lower training burden, active push-button or slide retraction emphasizes operational control, and blood-control or multi-access valves further enhance infection-control value. Since these products contact the vascular system directly and involve sterility, material compatibility, and sharps protection, market entry requires medical device registration, sterilization validation, material safety, needle-tip protection reliability, and batch consistency. Future competition will move from individual low-price products toward integrated solutions centered on clinical scenarios, nursing workflows, and full-size portfolios.
Future growth will concentrate on blood control, closed systems, power-injectable imaging applications, pediatric and neonatal sizes, and regional localization. Blood-control products can reduce leakage during cannulation and connection, making them suitable for emergency departments, ICUs, infection-control settings, and high-turnover wards. Closed systems reduce open connections and manual venous compression, helping improve nursing safety and workflow efficiency. Power-injectable safety IV catheters can be linked to CT contrast imaging and raise the application value of a single catheter. Pediatric and neonatal products require smaller gauges, lower trauma, stable flashback, and stronger contamination control. From a policy perspective, occupational exposure protection, bloodborne pathogen risk control, and registration review requirements for sterile single-use devices will continue to support product standardization. In terms of consumption regions, North America, Europe, and Japan tend to favor high-safety configurations and branded products, while China is shaped by tender procurement, domestic substitution, and upgraded hospital safety management. India and Southeast Asia combine local manufacturing with export potential. Overall, safety IV catheters remain a structural upgrade category within basic medical consumables, with long-term replacement space and steady growth characteristics.
This report is a detailed and comprehensive analysis for global Safety IV Catheter market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Blood Control and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Safety IV Catheter market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Safety IV Catheter market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Safety IV Catheter market size and forecasts, by Blood Control and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Safety IV Catheter market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Safety IV Catheter
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Safety IV Catheter market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun SE, ICU Medical, Inc., Becton, Dickinson and Company, JCM MED, Poly Medicure Limited, MedSource Labs, Terumo Corporation, Greiner Bio-One International GmbH, MEDIKIT Co., Ltd., Nipro Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Safety IV Catheter market is split by Blood Control and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Blood Control, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Blood Control
No Blood Control
Single Blood Control
Multiple Blood Control
Market segment by Structural Configuration
Wingless Straight
Winged
Market segment by Safety Mechanism
Active Retraction
Passive Clip
Other
Market segment by Application
Intravenous Infusion
Blood Sampling
Blood Pressure Monitoring
Other
Major players covered
B. Braun SE
ICU Medical, Inc.
Becton, Dickinson and Company
JCM MED
Poly Medicure Limited
MedSource Labs
Terumo Corporation
Greiner Bio-One International GmbH
MEDIKIT Co., Ltd.
Nipro Corporation
Vygon SA
Zhejiang Kindly Medical Devices Co., Ltd.
Suzhou Linhwa Medical Devices Co., Ltd.
PW Medtech Group Limited
Delta Med S.p.A.
Angiplast Pvt. Ltd.
Harsoria Healthcare Pvt. Ltd.
Woo Young Medical Co., Ltd.
Young Corporation
Forlong Medical Co., Ltd.
Kohope Medical Co., Ltd.
USM Healthcare Medical Devices Factory JSC
SBRG Medtech Pvt. Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Safety IV Catheter product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Safety IV Catheter, with price, sales quantity, revenue, and global market share of Safety IV Catheter from 2021 to 2026.
Chapter 3, the Safety IV Catheter competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Safety IV Catheter breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Blood Control and by Application, with sales market share and growth rate by Blood Control, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Safety IV Catheter market forecast, by regions, by Blood Control, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Safety IV Catheter.
Chapter 14 and 15, to describe Safety IV Catheter sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Safety IV Catheter. Industry analysis & Market Report on Safety IV Catheter is a syndicated market report, published as Global Safety IV Catheter Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Safety IV Catheter market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.